WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Sheetal Verma
PeerJ Editor
300 Points

Contributions by role

Editor 300

Contributions by subject area

Epidemiology
Infectious Diseases
Pathology
Public Health
COVID-19
Gastroenterology and Hepatology
Immunology
Surgery and Surgical Specialties
Translational Medicine
Anesthesiology and Pain Management
Emergency and Critical Care
Evidence Based Medicine

Sheetal Verma

PeerJ Editor

Summary

Dr. Sheetal Verma is an expert in the field of infectious disease immunology, and works primarily on host immune responses to Tuberculosis (TB). She has published extensively on characterization and validation of immuno-pathological pathways that modulate disease outcomes in TB.

In her current role, she is responsible for overseeing the implementation of scientific protocols and research operations at multiple international sites as part of the RePORT International Consortium. Dr. Verma works closely with the Data Management and Operations Center of RePORT International in coordinating cross-institutional regulatory processes, biorepository management and supervising assigned staff at international research laboratories.

She is a co-investigator on multiple NIH/NIAID grants and is a valued member of the Rutgers NJMS community, due to her skills in the practice and teaching of research in high containment Biosafety Level 3 Laboratories (BSL3). In this capacity, she leads training of new scientists in containment procedures, performing key experiments and designing applicable protocols for working with animal models.

Dr. Verma obtained her MS degree from Case Western Reserve University in 2010 and her PhD from Rutgers University - New Jersey Medical School in 2017.

Immunology Infectious Diseases

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Work details

Assistant Professor

Rutgers University
New Jersey Medical School

Websites

  • Google Scholar

PeerJ Contributions

  • Edited 3

Academic Editor on

October 2, 2025
Predictive performance of clinical scores and survival outcomes in critically ill patients with sepsis: a prospective longitudinal study at a tertiary medical centre in Ethiopia
Girum Tesfaye Kiya, Zeleke Mekonnen, Elsah Tegene Asefa, Edosa Kejela, Edosa Tadasa, Esayas Kebede Gudina, Tilahun Yemane, Gemeda Abebe
https://doi.org/10.7717/peerj.20109 PubMed 41054570
December 6, 2024
Effects of combined immunosuppressant and hepatitis B virus antiviral use on COVID-19 vaccination in recipients of living donor liver transplantation
Ryunjin Lee, Jiwan Choi, Eunkyeong Lee, Jooyoung Lee, Jiye Kim, Seoon Kang, Hye-In An, Sung-Han Kim, Sung-Min Kim, Eun-Kyoung Jwa, Gil-Chun Park, Jung-Man Namgoong, Gi-Won Song, Young-In Yoon, Eunyoung Tak, Sung-Gyu Lee
https://doi.org/10.7717/peerj.18651 PubMed 39655328
July 22, 2024
Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study
Martin Theuri, Eric M. Ndombi, Peris Thamaini, James Opiyo Ogutu, Lister Onsongo, June K. Madete, Victor Ofula, Samuel Gitau, Gladys Mwangi, Paul Okemo
https://doi.org/10.7717/peerj.17723 PubMed 39056056